Comparing antifungal treatments for invasive fungal disease
Part of Infections clinical trials.
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with an invasive fungal disease (a serious fungal infection inside your body).
- You have received treatment with either a polyene antifungal (like amphotericin B) or an azole antifungal (like fluconazole) for at least 7 days.
- You have medical records available with enough information for the study team to review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether amphotericin B can treat new fungal infections that develop in people with blood cancers even after they have taken preventive antifungal medicine. It may help patients who have a confirmed or suspected fungal infection while on that prevention.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This trial looks at how a specific antifungal medicine, called liposomal amphotericin B, given over a longer period, helps prevent serious fungal infections in people undergoing treatment for cancer or receiving a stem cell transplant. It may be an option if you are at high risk for these infections.
This study enrolls people who have test results showing an invasive fungal infection (a fungus causing illness inside the body). The goal is to build a global registry to better understand these infections and improve future care.
This study looks at how well antifungal medicines work against different fungi and how fungi become resistant. By joining, you may help doctors understand your infection and improve future treatments.
This study compares different antifungal medicines to see which works best for a serious lung fungal infection called pulmonary mucormycosis. If you have this infection and haven't had too much prior treatment, you might be able to join.
Hear when a new Invasive Fungal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.